Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)

Study ID: NCT05677360
Start Date: 2023-01-09
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

564

Intervention / Treatment

HPV MISTICS -Provider Level

HPV MISTICS - Parent Level

HPV MISTICS- HPV Vaccine Champion Level

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Impact of Financial Incentives

Study ID: NCT05744960
Start Date: 2023-02-28
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

Communication training

financial Incentive

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Study ID: NCT04645160
Start Date: 2022-03-04
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

31

Intervention / Treatment

Pucking

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Virtual Histology of the Bladder Wall for Bladder Cancer Staging

Study ID: NCT04369560
Start Date: 2021-01-06
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

42

Intervention / Treatment

Magnetic Resonance Imaging

Gadobutrol intravesical administration (4mM)

Ferumoxytol intravesical administration (5 mM)

Sponsor

If

Source: clinicaltrials.gov

Share:
Add to list

ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

Study ID: NCT06128304
Start Date: 2023-11-13
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2436

Intervention / Treatment

Core Implementation strategies

Core+ Enhanced Implementation Strategies

Sponsor

University of California, San Diego

Source: clinicaltrials.gov

Share:
Add to list

A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma

Study ID: NCT05249101
Start Date: 2022-08-15
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

Ivaltinostat

Capecitabine

Sponsor

CG Pharmaceuticals, Inc

Source: clinicaltrials.gov

Share:
Add to list

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Study ID: NCT05039801
Start Date: 2021-09-09
End Date: 2026-05-29
Study Type

Interventional

Study Phase

Phase1

No. of Participants

54

Intervention / Treatment

Infatuating

Glutaminase-1 Inhibitor IACS-6274

Paclitaxel

Capivasertib

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis

Study ID: NCT05301101
Start Date: 2022-06-13
End Date: 2027-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Re-irradiation

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

Study ID: NCT02772367
Start Date: 2016-05-11
End Date: 2026-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

skin punch biopsy

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Study ID: NCT05691491
Start Date: 2023-09-28
End Date: 2027-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

58

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Temozolomide

Stimulus

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list